medical cannabis
medical cannabis · page 49
- Cultivation
Guernsey receives seven applications for high-THC cultivation licences
Guernsey says that the majority of the applications received so far aim to produce cannabis-based medicinal products.
- Medical
Small scale cannabis cultivation set to be decriminalised in Italy
Italy could join Austria and Cyprus as one of the only countries to allow home cultivation for medicinal use.
- Companies
Panaxia to exit cannabis activities in Israel and focus on Europe
The company is looking forward to beginning products sales designed for the Oncology field in partnership with the German company, Axio-Novo, this year.
- Medical
First Denmark cannabis shipment reaches Australia’s Little Green Pharma
LGP received the shipment just over two months following the acquisition of its Danish facility.
- Medical
UK’s NCRI endorses research into cannabis for treating cancer pain
The development will give hope to cancer patients as current treatment options for cancer-related pain are largely ineffective.
- Companies
Cannabis Society conference to discuss European medical cannabis
The Cannabis Society is to host a conference this September that will discuss both European medical cannabis and North American multi-state operators (MSO) growth and consolidation.
- Companies
Flora investment in Hoshi paves way for European cannabis distribution
The move will see Flora’s finished cannabis products reach patients in Europe.
- Medical
Aurora fulfils first shipment for French medical cannabis programme
The products are set to be made available to patients in the coming weeks
- Companies
German and Colombian cannabis markets driving Khiron sales growth
Khiron has expanded its product offerings in both the UK and Germany.
- Medical
Grow group: innovating cannabis medicines and improving access
Grow Group co-founder and CEO Ben Langley spoke about the company’s aims, cannabis innovation and its plans for expansion.
- Cultivation
Cannabis genetics to be developed for specific healthcare applications
Swiss Life Sciences says it aims to improve on cannabis medicines that are already being successfully used in treatments with elite genetics.
- Medical
Understanding the future of patient access to medical cannabis
On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What’s Next?”
